Vertex For Fetal Hemoglobin Researchers report promising results from a study examining a CRISPR-based treatment for sickle-cell disease, according to the Associated Press. Doing Well After a Year NPR reports that the first person in the US to undergo a CRISPR-based treatment for sickle-cell disease continues to do well nearly a year after treatment. Promising, But More Needed Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease. Treatment So Far NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well. To Turn on the Other Hemoglobin Doctors in the US have used CRISPR gene editing to try to treat a woman with sickle cell disease as part of a clinical trial, according to Popular Science. Feb 26, 2014 FDA Approves Vertex's Kalydeco in Cystic Fibrosis Patients with Eight Additional Mutations Premium Jul 31, 2013 With Positive Trial Data, Vertex to Seek Approval for CF Drug in New Genetically Defined Population Premium Aug 1, 2012 MDx/CDx Focus: EC Approves Kalydeco; Cabozantinib in PGx-Targeted NSCLC; Ponatinib, CDx FDA Filing Premium May 30, 2012 People in the News: David Rimoin, David Altshuler Premium May 30, 2012 People in the News: David Altshuler Premium May 23, 2012 Vertex Says CF Patients with Double F508del Mutation Showing Improvement in VX-809/Kalydeco Trial Premium Feb 1, 2012 MDx/CDx Focus: FDA Accepts Pfizer's Bosutinib NDA; Kalydeco Approval; AssureRx Credit Line; and more Premium Oct 22, 2010 Caprion Identifies Protein Biomarkers for Predicting Patient Response to New Hepatitis C Drug Premium Jun 30, 2009 Ohio Awards Public-Private Stem-Cell Consortium $5M to Help Market Its Discoveries Premium Mar 2, 2009 Mass. to Use $2.5M of Life-Sci Act to Give Younger Researchers Leg-Up in Industry Premium Feb 2, 2009 BioRegion Newsmakers: Feb 2, 2009 Premium Breaking News MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates Horse Genetics Study Reveals Origins of Domestication, Use in Human Culture Rady Children's Team Presents Genomic Medicine Management Tool at ASHG The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.